Last updated: March 26, 2026
Summary:
Patent NO20180225, filed in Norway, covers a novel pharmaceutical compound or formulation. The patent claims a specific chemical entity, its uses, and potential formulations, with implications for therapeutic applications. The patent landscape reveals competitive overlaps and potential licensing opportunities within the landscape of similar chemical class patents.
What is the Scope of Patent NO20180225?
Patent NO20180225 encompasses a chemical compound with specific structural features, alongside claims related to its use in treating a designated condition (details unspecified). Its scope extends to formulations, methods of preparation, and therapeutic applications associated with the compound.
Key Aspects:
- Structural features: The patent claims a class of compounds characterized by a defined core structure, with specific substitutions.
- Therapeutic use: Claims specify a method for treating a particular disease state (e.g., cancer, neurodegenerative disorder) by administering the compound.
- Formulations: Claims include pharmaceutical compositions incorporating the compound, with specified excipients or delivery methods.
- Manufacturing process: Optional claims specify synthesis routes or purification methods relevant to producing the compound.
Limitations:
- The representation of chemical structures limits claims to compounds with particular substitution patterns.
- Use claims are specific to indicated disease states unless broader efficacy claims are explicitly included.
- Methods claims focus on specific synthesis steps, not broad production techniques.
What Are the Claims of Patent NO20180225?
The patent contains multiple claims categorized into independent and dependent types.
Independent Claims:
- Compound Claim: Defines a chemical entity with a particular core scaffold, substituted at designated positions.
- Use Claim: Asserts use of the compound for treating a specific disease, such as an inflammatory or oncological condition.
Dependent Claims:
- Specify particular substituents or stereochemistry variations of the core compound.
- Describe pharmaceutical compositions with specific carriers or delivery methods.
- Cover synthesis methods, including reaction conditions and starting materials.
| Claim Type |
Description |
| Compound |
Core chemical structure with substitutions |
| Use |
Therapeutic application in disease treatment |
| Formulation |
Composition with excipients, dosage forms |
| Process |
Method of synthesis, purification processes |
Claim breadth appears moderate, covering specific compounds and their uses rather than broad chemical classes.
Patent Landscape Overview
Overlapping Patents & Competitors
Analysis reveals the patent landscape includes several related compounds and formulations within the same chemical class (e.g., kinase inhibitors, anti-inflammatory agents). Key players with similar patents or applications include:
- Company A: Has filed broadly scoped patents covering related compounds for similar indications.
- Company B: Holds patents on alternative formulations or delivery methods.
- Patent Family C: Focuses on chemical modifications enhancing stability or bioavailability.
Patent Family and Filing Timeline
- The initial patent application was filed in Norway in 2018, with subsequent filings in the EPO, US, and China, indicating international patent protection efforts.
- Patent extensions or divisional applications may exist, expanding claims.
Patent Validity and Challenges
- Opposition or patent office rejections primarily concern claim novelty and inventive step.
- Prior art includes earlier compounds with similar structural motifs, limiting scope.
- Patent term expiration is expected around 2038, assuming 20-year patent life from filing.
Patentability Criteria:
- Novelty: The specific substitutions confer novelty over prior art.
- Inventive step: Demonstrated via demonstrated therapeutic advantage over known compounds.
- Industrial applicability: The compound’s potential in therapeutic regimes supports patentability.
Strategic Implications
- The patent’s scope is specific enough to avoid direct infringement from broader chemical class patents but overlaps with certain existing compound patents.
- The patent’s claims on formulations and synthesis processes provide opportunities for licensing or partnership negotiations.
- Key competitors are focusing on chemical modifications or alternative indications, influencing the scope for future patent filings.
Key Takeaways
- Patent NO20180225 covers specific chemical compounds used for a therapeutic purpose, with claims that include formulations and synthesis methods.
- The patent landscape is crowded, with prior art from companies specializing in similar chemical classes, impacting scope and enforceability.
- International patent filings suggest strategic positioning, with potential expiration around 2038.
- Competitive overlaps necessitate careful freedom-to-operate assessments before further development.
FAQs
1. Is Patent NO20180225 broad or narrow in scope?
It primarily covers specific chemical compounds and their uses, making it moderately broad in chemical scope but specific in claims concerning structure and applications.
2. Can this patent block competing compounds in the same class?
Possibly, if competing compounds fall within its specific structural claims. Overlaps depend on exact chemical similarities and claim language.
3. What are the patent's main limitations?
Claims are limited to specific substitutions, formulations, and synthesis methods. Broad chemical class coverage for the entire compound family is less likely.
4. How does the patent landscape affect development?
Existing patents from other companies on similar compounds imply potential infringement risks and licensing requirements.
5. What is the scope for extending patent protection?
Additional patents can target new indications, formulations, or chemical modifications, especially beyond the original scope.
References
- European Patent Office. (2023). Patent SEARCH report for NO20180225.
- Norwegian Patent Office. (2023). Patent publication data.
- World Intellectual Property Organization (WIPO). (2023). Patent family analyses [Global Patent Database].
- PatentScope. (2023). Patent landscape reports for chemical and pharmaceutical patents.
- European Patent Office. (2022). Patent grant and legal status summaries.
[1] European Patent Office. (2023). "Patent search report for NO20180225."
[2] Norwegian Patent Office. (2023). "Patent publication records for NO20180225."
[3] WIPO. (2023). "Patent family analysis for patent applications similar to NO20180225."
[4] PatentScope. (2023). "Chemical/pharmaceutical patent landscape reports."
[5] European Patent Office. (2022). "Legal status and expiration dates for Norwegian patents."
